Modified GRF Growth Releasing Factor 1-29 Growth Hormone Peptides For Test Pregnancy

Modified GRF (Growth Releasing Factor) 1-29, sometimes referred to as CJC-1295 no DAC, is a synthetic GHRH (Growth Hormone Releasing Hormone). Naturally occurring GHRH has forty-four amino acids in its structure. Sermorelin, sometimes referred to as Modified GRF (1-29), has twenty nine amino acids in its structure.

Modified GRF ( Growth Releasing Factor ) 1-29 For Test Pregnancy

Unlike Sermorelin, four of the amino acids in the structure of Modified GRF (1-29) have been replaced in order to avoid oxidation and deterioration in the manufacturing and storage process. Additionally, the Modified GRF (1-29) will not metabolize rapidly in plasma.

Modified GRF (1-29) Quick View:

Modified GRF (1-29) Descriptions:

Modified GRF (1-29) has a peptide purity level that exceeds 99.0% as determined by HPLC. Modified GRF (1-29) was synthesized with no additives and is supplied as a white lyophilized (freeze-dried) powder.

Modified GRF (1-29) often abbreviated as mod GRF (1-29), originally known as tetrasubstitued GRF (1-29), is a term used to identify a 29 amino acid peptide analogue of growth-hormone-releasing hormone (GHRH), a releasing hormone of growth hormone (GH). It is a modified version of the shortest fully functional fragment of GHRH, often referred to as growth hormone releasing factor (1-29) (abbreviated as GRF (1-29)), and also known by its standardized name, sermorelin.

Solubility & Storage:

It is recommended to reconstitute the lyophilized Modified GRF (1-29) in sterile water, which can then be further diluted in other aqueous solutions. Lyophilized Modified GRF (1-29) although stable at room temperature for 3-4 weeks, should be stored desiccated below -18°C. Upon reconstitution, Modified GRF (1-29) should be stored at 4°C out of direct light for between 10-14 days and for future use below -18°C. Prevent repeated freeze-thaw cycles.

Modified GRF (1-29) Usage:

Modified GRF (1-29) has been synthesized for in-vitro laboratory studies to be performed with cells or biological molecules. Modified GRF (1-29) is not a drug and has not been approved by the FDA to prevent or cure any medical condition or disease. The purchaser is solely liable for risk involved with using this product for any purpose outside of in vitro studies.

Peptide List: